期刊文献+

快速破坏性髋关节骨关节炎患者体重、身高指数及骨密度分析 被引量:5

Analysis of body mass index and bone mineral density in patients with rapidly destructive hip osteoarthritis
下载PDF
导出
摘要 目的探讨快速破坏性髋关节骨关节炎(RDHOA)是否与体重身高指数(body mass index,BMI)、骨密度(bone mineral density,BMD)有关。方法对比分析8例快速破坏性髋关节骨关节炎患者与8例健康老年人的BMI、跟骨BMD。结果快速破坏性髋关节骨关节炎与健康老年人的BMI、跟骨BMD数据差异无统计学意义。结论快速破坏性髋关节骨关节炎与患者的体重身高指数、骨密度无关。 Objective To investigate the relationship among rapidly destructive hip osteoarthritis (RDHOA) , the body mass index (BMI), and the bone mineral density (BMD). Methods Eight patients who were diagnosed with rapidly destructive hip osteoarthritis and eight healthy elderly people were selected. BMI and the BMD of the calcaneous were compared and analyzed. Results BMI and the BMD of the calcaneous in patients with RDHOA and healthy elderly people were not significantly different. Conclusion Rapidly destructive hip osteoarthritis has no correlation with BMI and BMD.
出处 《中国骨质疏松杂志》 CAS CSCD 北大核心 2013年第9期970-972,共3页 Chinese Journal of Osteoporosis
关键词 髋关节骨关节炎 快速 破坏性 体重身高指数 骨密度 Hip osteoarthritis Rapidly Destructive Body mass index Bone mineral density
  • 相关文献

参考文献2

二级参考文献27

  • 1李保林,周正新,王海彬,何伟,袁浩.股骨头坏死关节软骨金属蛋白酶的表达[J].实用骨科杂志,2004,10(3):224-226. 被引量:7
  • 2戴戎,董凡,王以友,唐坚.三种髋关节功能评定方法的比较研究[J].中华外科杂志,1994,32(9):535-538. 被引量:21
  • 3赵凤朝,李子荣,张念非.不同病因股骨头坏死的病理改变[J].实用骨科杂志,2005,11(3):210-213. 被引量:25
  • 4Rosenberg ZS,Shankman S,Steiner GC,et al.Rapidly destructive osteoarthritis:clinical,radiographic,and pathologic features.Radiology.1992;182(1):213-216.
  • 5Ogawa K,Mawatari M,Komine M,et al.Mature and activated osteoclasts exist in the synovium of rapidly destructive coxarthrosis.J Bone Miner Metab.2007;25(5):354-360.
  • 6Mitrovic DR,Riera H.Synovial,articular cartilage and bone changes in rapidly destructive arthropathy(osteoarthritis)of the hip.Rheumatol Int.1992;12:17-22.
  • 7Rosen HN,Moses AC,Garber J,et al.Serum CTX:a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy.Calcify Tissue Int.2000; 66(2):100-103.
  • 8Chao TY,Wu YY,Janckila AJ.Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.Clin Chim Acta.2010;411(21-22):1553-1564.
  • 9Tauchert S,di Liberto A,Cordes T,et al.Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases.Clin Exp Obstet Gynecol.2009;36(4):219-225.
  • 10Dam EB,Byrjalsen I,Karsdal MA,et al.Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI.Osteoarthritis Cartilage.2009; 17(3):384-389.

共引文献13

同被引文献40

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部